Mitek Systems, Inc. (NASDAQ:MITK), the leading innovator in mobile imaging for financial transactions, announced that another top 30 U.S. bank has licensed Mobile Deposit(R) and Mobile Photo Bill Pay(R) . The deal closed during Mitek’s second fiscal quarter and is scheduled to be available to this bank’s customers later this year. Mitek’s Mobile Deposit is currently used by tens of millions of consumers and implemented by all top ten banks in the U.S. Mitek Systems, Inc. (NASDAQ:MITK) shares after opening at $3.73 on last trade day and at the end of the day closed at $3.69. Company price to sales ratio in past twelve months was calculated as 7.01 and price to cash ratio as 4.79. Mitek Systems, Inc. (NASDAQ:MITK) showed a negative weekly performance of -12.77%.
Celgene Corporation (CELG) and Acceleron Pharma Inc (NASDAQ:XLRN), announced the publication of two papers available online and in the April issue of the journal Nature Medicine that describe how sotatercept and ACE-536 promote red blood cell formation through an erythropoietin (EPO) independent mechanism in mice. EPO stimulates the proliferation of early-stage red blood cell precursors to form new red blood cells. However, anemias associated with defects in the late-stages of red blood cell formation, known as ineffective erythropoiesis, are resistant to EPO treatment. These studies suggest that sotatercept and ACE-536 may promote and regulate the maturation of late-stage red blood cell precursors and this distinct activity supports the rationale for sotatercept and ACE-536 as potential novel therapies to correct anemia, including the EPO-resistant anemia, in diseases such as beta-thalassemia and myelodysplastic syndromes. Acceleron Pharma Inc (NASDAQ:XLRN) shares fell -5.59% in last trading session and ended the day on $198.80. XLRN return on equity ratio is recorded as 66.70% and its return on assets is -156.00%.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) has earned an average recommendation of “Buy” from the eight analysts that are covering the company, Analyst Ratings.Net reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $17.67. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) shares moved up 0.50% in last trading session and was closed at $10.12, while trading in range of $9.85 – 10.70. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) year to date (YTD) performance is -25.15%.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Western District of Oklahoma on behalf of investors who held Equal Energy Ltd. (USA) (NYSE:EQU) common stock on December 9, 2013. Equal Energy Ltd. (USA) (NYSE:EQU) weekly performance is -4.08%. On last trading day company shares ended up $4.47. Equal Energy Ltd. (USA) (NYSE:EQU) distance from 50-day simple moving average (SMA50) is -14.26%. Analysts mean target price for the company is $5.75.